Related references
Note: Only part of the references are listed.Is Frequent CD4+ T-Lymphocyte Count Monitoring Necessary for Persons With Counts ≥300 Cells/μL and HIV-1 Suppression?
Howard B. Gale et al.
CLINICAL INFECTIOUS DISEASES (2013)
Quantifying beta-Cells in Health and Disease: The Past, the Present, and the Need
Steven E. Kahn
DIABETES CARE (2013)
Updated US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Postexposure Prophylaxis
David T. Kuhar et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2013)
Antiretroviral Treatment of Adult HIV Infection 2012 Recommendations of the International Antiviral Society-USA Panel
Melanie A. Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
JOURNAL OF HEPATOLOGY (2011)
Adolescents and HIV Infection: The Pediatrician's Role in Promoting Routine Testing
Patricia M. Flynn et al.
PEDIATRICS (2011)
Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America
Judith A. Aberg et al.
CLINICAL INFECTIOUS DISEASES (2009)
GRADE:: going from evidence to recommendations
Gordon H. Guyatt et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
GRADE:: what is quality of evidence and why is it important to clinicians?
Gordon H. Guyatt et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America
SK Gupta et al.
CLINICAL INFECTIOUS DISEASES (2005)
Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy:: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group
MP Dubé et al.
CLINICAL INFECTIOUS DISEASES (2003)
Share Paper
